EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The Impact of QSP Modeling on the Design and Optimization of Gene Therapy Approaches

Noha Rayad iD, Ekram A Chowdhury iD, Guy M L Meno-Tetang iD

CPT: Pharmacometrics & Systems Pharmacology · 2025

DOI: 10.1002/psp4.70131 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2025. Verfasst von Noha Rayad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology & Safety Sciences, Alexion, AstraZeneca Rare Disease, Mississauga, Ontario, Canada. Hauptthemen laut MEDLINE: Genetic Therapy, Models, Biological. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Quantitative Systems Pharmacology (QSP) is increasingly utilized to support the design and translation of gene therapies. This perspective outlines the application of QSP modeling across three domains of gene therapy: mRNA‐based therapeutics, adeno‐associated virus (AAV) vectors, and genome editing systems. We highlight opportunities for dose optimization, biomarker interpretation, and mechanistic understanding, while addressing current limitations in model generalizability, data sparsity, and translational relevance. Examples include QSP platforms for lipid nanoparticle (LNP)‐delivered mRNA, physiologically based pharmacokinetics (PBPK)‐informed AAV biodistribution models, and CRISPR‐Cas9‐based editing systems. These case studies demonstrate QSP's value in de‐risking development and personalizing therapies for rare and complex diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyModels, BiologicalHumansGene EditingDependovirusGenetic VectorsAnimalsRNA, MessengerNanoparticlesCRISPR-Cas SystemsLipidsTissue DistributionLiposomes

Substanzen

RNA, MessengerLipidsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Clinical Pharmacology & Safety Sciences, Alexion, AstraZeneca Rare Disease, Mississauga, Ontario, Canada.
  • Clinical Pharmacology & Pharmacometrics, AbbVie, North Chicago, Illinois, USA.
  • Neuroscience, R&D Biopharmaceuticals, AstraZeneca, Cambridge, UK.

ORCID-Profile: Noha Rayad, Ekram A Chowdhury, Guy M L Meno-Tetang

Zitieren

APA

Rayad, N., Chowdhury, E. A., & Meno-Tetang, G. M. L. (2025). The Impact of QSP Modeling on the Design and Optimization of Gene Therapy Approaches. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.70131

Vancouver

Rayad N, Chowdhury EA, Meno-Tetang GML. The Impact of QSP Modeling on the Design and Optimization of Gene Therapy Approaches. CPT: Pharmacometrics & Systems Pharmacology. 2025. doi:10.1002/psp4.70131

BibTeX
@article{Rayad2025,
  author = {Rayad, Noha and Chowdhury, Ekram A and Meno-Tetang, Guy M L},
  title = {The Impact of QSP Modeling on the Design and Optimization of Gene Therapy Approaches},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2025},
  doi = {10.1002/psp4.70131}
}
Kostenlos starten →